This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hidaka, S. Articles by Tagawa, Y. Search for Related Content PubMed PubMed Citation Articles by Hidaka, S. Articles by Tagawa, Y.

Differences in 20q13.2 Copy Number between Colorectal Cancers with and without Liver Metastasis

The First Department of Surgery, Nagasaki University School of Medicine, Nagasaki 852-8501 [S. H., T. Y., H. T., M. K., T. T., A. N., T. S., H. Y., T. N., H. A.], and School of Allied Medical Sciences, Nagasaki University, Nagasaki 852-8520 [Y. T.], Japan

Frequent gains of 20q have been identified recently in many neoplasias, including breast, bladder, ovarian, pancreatic, and colon cancers. A high level of 20q13.2 amplification is associated with poor prognosis in breast cancer. We investigated the copy number of the 20q13.2 region including the ZNF217 oncogene in 17 nonmetastatic colorectal cancers (CRCs), 18 primary CRC tumors with liver metastasis, and 18 metastatic lesions by two-color fluorescence in situ hybridization to evaluate the significance of an increased copy number of 20q13.2 in CRC, especially in those cases with liver metastasis. The frequency of increased relative copy number of the 20q13.2 region was higher in primary and liver metastatic lesions of CRC than in CRC lesions without liver metastasis. In particular, a high-level increase (>3.0-fold) in the relative copy number of 20q13.2 was observed in 2 of 18 (11%) primary CRC lesions with liver metastasis, 7 of 18 (39%) liver metastatic lesions, and in none of the cases of primary CRC without liver metastasis. The absolute and relative copy number of chromosome 20q13.2 was higher in CRCs with metastasis than in CRCs without metastasis. The percentage of cells with high-level 20q13.2 amplification was also higher in both lesions with metastasis per specimen than without metastasis. Our results suggest that the level of 20q13.2 amplification correlates with the metastatic potential and tumor progression of CRC. The results also suggest that 20q13.2 amplification with ZNF217 is associated with increased metastatic potential.

This article has been cited by other articles:

				G. Thillainadesan, M. Isovic, E. Loney, J. Andrews, M. Tini, and J. Torchia Genome Analysis Identifies the p15ink4b Tumor Suppressor as a Direct Target of the ZNF217/CoREST Complex Mol. Cell. Biol., October 1, 2008; 28(19): 6066 - 6077. [Abstract] [Full Text] [PDF]

				J. Camps, G. Armengol, J. del Rey, J. J. Lozano, H. Vauhkonen, E. Prat, J. Egozcue, L. Sumoy, S. Knuutila, and R. Miro Genome-wide differences between microsatellite stable and unstable colorectal tumors Carcinogenesis, March 1, 2006; 27(3): 419 - 428. [Abstract] [Full Text] [PDF]

				S. H. Yang, M. Y. Seo, H. J. Jeong, H.-C. Jeung, J. Shin, S. C. Kim, S. H. Noh, H. C. Chung, and S. Y. Rha Gene Copy Number Change Events at Chromosome 20 and Their Association with Recurrence in Gastric Cancer Patients Clin. Cancer Res., January 15, 2005; 11(2): 612 - 620. [Abstract] [Full Text] [PDF]

				T. Sun, X. Miao, J. Wang, W. Tan, Y. Zhou, C. Yu, and D. Lin Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma Carcinogenesis, November 1, 2004; 25(11): 2225 - 2230. [Abstract] [Full Text] [PDF]

				K. Nakao, K. R. Mehta, J. Fridlyand, D. H. Moore, A. N. Jain, A. Lafuente, J. W. Wiencke, J. P. Terdiman, and F. M. Waldman High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization Carcinogenesis, August 1, 2004; 25(8): 1345 - 1357. [Abstract] [Full Text] [PDF]

				X. Miao, T. Sun, Y. Wang, X. Zhang, W. Tan, and D. Lin Functional STK15 Phe31Ile Polymorphism Is Associated with the Occurrence and Advanced Disease Status of Esophageal Squamous Cell Carcinoma Cancer Res., April 15, 2004; 64(8): 2680 - 2683. [Abstract] [Full Text] [PDF]

				A. Leslie, N. R. Pratt, K. Gillespie, M. Sales, N. M. Kernohan, G. Smith, C. R. Wolf, F. A. Carey, and R. J. C. Steele Mutations of APC, K-ras, and p53 Are Associated with Specific Chromosomal Aberrations in Colorectal Adenocarcinomas Cancer Res., August 1, 2003; 63(15): 4656 - 4661. [Abstract] [Full Text] [PDF]

				C. B. Diep, L. Thorstensen, G. I. Meling, E. Skovlund, T. O. Rognum, and R. A. Lothe Genetic Tumor Markers With Prognostic Impact in Dukes' Stages B and C Colorectal Cancer Patients J. Clin. Oncol., March 1, 2003; 21(5): 820 - 829. [Abstract] [Full Text] [PDF]

				C. L. Andersen, O. Monni, U. Wagner, J. Kononen, M. Barlund, C. Bucher, P. Haas, A. Nocito, H. Bissig, G. Sauter, et al. High-Throughput Copy Number Analysis of 17q23 in 3520 Tissue Specimens by Fluorescence in Situ Hybridization to Tissue Microarrays Am. J. Pathol., July 1, 2002; 161(1): 73 - 79. [Abstract] [Full Text] [PDF]

				T. Ueno, A. Tangoku, S. Yoshino, T. Abe, H. Toshimitsu, T. Furuya, S. Kawauchi, A. Oga, M. Oka, and K. Sasaki Gain of 5p15 Detected by Comparative Genomic Hybridization as an Independent Marker of Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma Clin. Cancer Res., February 1, 2002; 8(2): 526 - 533. [Abstract] [Full Text] [PDF]